Investments

Building in good company.

Company

Description

Sector

Region

Year Invested

Year Exited

Seaport Therapeutics

Seaport Therapeutics is a clinical-stage biopharmaceutical company developing neuropsychiatric medicines in areas of unmet patient needs.
View Site

Life Sciences

United States

2024

1970

Verdiva Bio

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and other cardiometabolic disorders.
View Site

Life Sciences

EMEA

2024

1970

Wuxi XDC

WuXi XDC provides single-source discovery, development & manufacturing services for antibody drug conjugates and other novel bioconjugates.
View Site

Life Sciences

China

2023

2024

Akero Therapeutics

Akero Therapeutics is a clinical stage biotechnology company developing novel therapies for patients with non-alcoholic steatohepatitis.
View Site

Life Sciences

United States

2023

1970

Acelyrin

Acelyrin is a late-stage clinical biotech company focused on acquiring and accelerating the development of immunology medicines.
View Site

Life Sciences

United States

2023

1970

Karuna Therapeutics

Karuna Therapeutics is a clinical-stage biotech company developing a novel drug for schizophrenia and Alzheimer’s Disease related psychosis.
View Site

Life Sciences

United States

2022

2024

Lepure Biotech

LePure is a provider of single-use bioprocess solutions for biopharmaceutical companies in China.
View Site

Life Sciences

China

2022

1970

Javara

Javara is an integrated research organization that partners with healthcare providers to conduct clinical trials.
View Site

Life Sciences

United States

2022

1970

WuXi Biologics

WuXi Biologics a contract development and manufacturing organization that provides outsourcing services for pharmaceutical and biotechnology companies in all stages of the biologics development process.
View Site

Life Sciences

China

2022

1970

Solve Therapeutics

Solve Therapeutics is a biopharmaceutical company that develops next-gen antibody-drug conjugates and bispecific therapeutics for cancer.
View Site

Life Sciences

United States

2021

1970

Third Harmonic Bio

Third Harmonic Bio is a clinical stage biotechnology company developing an oral KIT inhibitor therapy for allergic autoimmune disorders.
View Site

Life Sciences

United States

2021

1970

Ultima Genomics

Ultima Genomics focuses on developing next-generation genome sequencing technology for the high-volume research and clinical markets.
View Site

Life Sciences

United States

2021

1970

CinCor Pharma

CinCor Pharma is a clinical-stage biopharmaceutical company with a mission to bring innovation to the treatment of hypertension.
View Site

Life Sciences

United States

2021

2023

Genesis MedTech

Genesis MedTech is a medical technology and device platform focused on the emerging markets.
View Site

Life Sciences

China

2021

1970

Biotheus

Biotheus is a clinical development stage company treating cancer and autoimmune diseases through next-generation therapeutics.
View Site

Life Sciences

EMEA

2021

1970

Centessa Pharmaceuticals

Centessa Pharmaceuticals is a next-gen biopharmaceutical company reshaping traditional drug development with its asset-centric R&D model.
View Site

Life Sciences

United States

2021

1970

KG Bio

KGBio is a clinical-stage biotech company focused on the in-licensing, clinical development, and manufacturing of biological products.
View Site

Life Sciences

Southeast Asia

2021

1970

Pharvaris

Pharvaris is a clinical-stage company focused on the discovery and development of treatments for hereditary angioedema.
View Site

Life Sciences

EMEA

2020

1970

HUTCHMED

HUTCHMED is a biopharmaceutical company focused on discovering, developing, and commercializing cancer and immunology therapies.
View Site

Life Sciences

China

2020

1970

CANbridge

CANbridge is a biotechnology company focused on developing and commercializing rare disease therapeutics in China.
View Site

Life Sciences

China

2020

1970

SciNeuro

SciNeuro is a clinical-stage biotechnology company that develops innovative medicines for patients with central nervous system diseases.
View Site

Life Sciences

China

2020

1970

Royalty Pharma

Royalty Pharma is an innovative biopharma company with a portfolio of commercial and pre-commercial drug royalties.
View Site

Life Sciences

United States

2020

1970

Adagene

Adagene is a clinical-stage biotechnology company focused on developing innovative antibodies with superior safety and efficacy profiles.
View Site

Life Sciences

China

2019

1970

Allonnia

Allonnia engineers breakthrough systems to develop and commercialize new waste remediation and management solutions.
View Site

Life Sciences

United States

2019

1970